Medicinal product with the designation Dysport® (ATC-code: M03AX21)
AOK Sachsen - Anhalt, MagdeburgTED 766696-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Results
38,753 open tenders
CountryTenderValueClosesDays left
Medicines with the designation Botox® (ATC code: M03AX21)
AOK Sachsen - Anhalt, MagdeburgTED 767622-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Medicines with the active combination Timolol and Tafluprost (ATC: S01ED70)
AOK Sachsen - Anhalt, MagdeburgTED 765869-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Medicines with the Active Substance Tocilizumab (ATC: L04AC07 - for subcutaneous use)
AOK Sachsen - Anhalt, MagdeburgTED 765560-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Medicines with the active ingredient Raltegravir (ATC: J05AJ01)
AOK Sachsen - Anhalt, MagdeburgTED 767434-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Medicines with the active ingredient Distigmine (ATC: N07AA03)
AOK Sachsen - Anhalt, MagdeburgTED 766045-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Medicines with the Active Substance Pazopanib (ATC: L01EX03)
AOK Sachsen - Anhalt, MagdeburgTED 765867-2025
value not stated1 lot, 2 years
Sun 31 Oct
367days
Contrast media - Cross-sector open-house procedure for the KV region Westfalen-Lippe
AOK NordWest, HagenTED 779421-2025
€13 lots, 2 years
Sun 31 Oct12:00 in Berlin
367days
Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Certolizumab pegol (WHO ATC Code: L04AB05)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 617680-2026
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open House Original Discount Contracts 2025-30 - Afatinib
Techniker Krankenkasse, HamburgTED 628921-2025
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Conclusion of non-exclusive discount agreements for medicinal products under § 130a para. 8 of the German Social Security Code (SGB V) via an Open-House model for the active substance Tacrolimus (WHO ATC code: L04AD02), limited to the dosage form
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 632634-2026
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open-House - Biologika Discount Contracts 2025-26 - Insulin Lispro (ATC: A10AB04, Strength: 100 U/ml)
Techniker Krankenkasse, HamburgTED 589353-2025
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Tacrolimus (WHO ATC Code: L04AD02)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 630574-2026
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open House Discount Contracts 2025-12
Techniker Krankenkasse, HamburgTED 615877-2025
value not stated15 lots
Sun 31 Oct23:58 in Berlin
367days
Open-House Contracts for Biologics Discounts 2025-29 - Omalizumab
Techniker Krankenkasse, HamburgTED 347743-2026
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open House Original Discount Agreements 2025-28 - Abemaciclib
Techniker Krankenkasse, HamburgTED 610267-2025
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Non-exclusive Drug Discount Agreement under § 130a para. 8 SGB V via Open-House Model for the Active Substance Testosterone (WHO ATC Code: G03BA03), with Restrictions
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen, ErfurtTED 617998-2026
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open House Original Discount Contracts 2025-27 - Ribociclib
Techniker Krankenkasse, HamburgTED 612458-2025
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open House Originale Discount Contracts 2025-26 - Ponesimod
Techniker Krankenkasse, HamburgTED 586433-2025
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
Open House Original Discount Contracts 2025-29 - Isavuconazole
Techniker Krankenkasse, HamburgTED 622464-2025
value not stated1 lot
Sun 31 Oct23:58 in Berlin
367days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.